SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-020875
Filing Date
2016-11-04
Accepted
2016-11-04 17:30:23
Documents
74
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aegr-093016x10q.htm 10-Q 1543687
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 42520
3 EXHIBIT 10.2 exhibit102.htm EX-10.2 78850
4 EXHIBIT 10.3 exhibit103.htm EX-10.3 25629
5 EXHIBIT 31.1 aegr-20160930_exhibit311.htm EX-31.1 12251
6 EXHIBIT 31.2 aegr-20160930_exhibit312.htm EX-31.2 12263
7 EXHIBIT 32.1 aegr-20160930_exhibit321.htm EX-32.1 5798
8 EXHIBIT 32.2 aegr-20160930_exhibit322.htm EX-32.2 5925
  Complete submission text file 0001628280-16-020875.txt   6525375

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aegr-20160930.xml EX-101.INS 1084458
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aegr-20160930.xsd EX-101.SCH 47259
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aegr-20160930_cal.xml EX-101.CAL 78576
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aegr-20160930_def.xml EX-101.DEF 210668
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aegr-20160930_lab.xml EX-101.LAB 657670
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aegr-20160930_pre.xml EX-101.PRE 379891
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 161976088
SIC: 2834 Pharmaceutical Preparations